Vor Biopharma (VOR) Return on Equity (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Return on Equity data on file, last reported at 0.02% in Q1 2026.

• Return on Equity for Q1 2026 came in at 0.02%, down 5.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.02% (down 5.0% YoY), and the FY2025 annual result was 0.03%, up 7.0% from the prior year.
• Return on Equity improved to 0.02% in Q1 2026 per VOR's latest filing, from 0.0% in the prior quarter.
• Over five years, Return on Equity peaked at 0.1% in Q4 2024 and troughed at 0.01% in Q3 2024.
• A 5-year average of 0.01% and a median of 0.0% in 2022 frame the typical range for Return on Equity.
• The sharpest annual moves came in 2024 and 2025: Return on Equity advanced 11 bps in 2024, then retreated 10 bps in 2025.
• A 5-year view of Return on Equity shows it stood at 0.0% in 2022, then slumped by 61 bps to 0.01% in 2023, then soared by 1462 bps to 0.1% in 2024, then slumped by 97 bps to 0.0% in 2025, then jumped by 657 bps to 0.02% in 2026.
• Business Quant data shows VOR's Return on Equity at 0.02% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.